SUMOylation determines turnover and localization of nephrin at the plasma membrane

Kidney International

Volumn 86, Issue 6, 2014, Pages 1161-1173

  Tossidou, Irini ^a   Himmelseher, Erik ^a   Teng, Beina ^a   Haller, Hermann ^a   Schiffer, Mario ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Endocytosis; Glomerular disease; Glomerular filtration barrier

Indexed keywords

ARGININE; E1A PROTEIN; LACTACYSTIN; LYSINE; METABOTROPIC RECEPTOR 8; NEPHRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN UBC9; SMAD3 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; SUMO PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UBIQUITIN; GINKGOLIC ACID; MEMBRANE PROTEIN; SALICYLIC ACID DERIVATIVE; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN-CONJUGATING ENZYME UBC9;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; GLOMERULAR FILTRATION BARRIER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEINURIA; SIGNAL TRANSDUCTION; STEADY STATE; SUMOYLATION; UBIQUITINATION; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; GLOMERULUS; HEK293 CELL LINE; METABOLISM;

ANIMALS; ARGININE; CELL MEMBRANE; HEK293 CELLS; HUMANS; KIDNEY GLOMERULUS; LYSINE; MALE; MEMBRANE PROTEINS; MICE; PODOCYTES; PROTEINURIA; SALICYLATES; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; TRANSFECTION; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84926227738     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.198     Document Type: Article

References (32)

1. Jones N, Blasutig IM, Eremina V et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006; 440: 818-823.
2. Verma R, Kovari I, Soofi A et al. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest 2006; 116: 1346-1359.
3. Kestila M, Lenkkeri U, Mannikko M et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998; 1: 575-582.
4. Putaala H, Soininen R, Kilpelainen P et al. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001; 10: 1-8.
5. Ruotsalainen V, Ljungberg P, Wartiovaara J et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 1999; 96: 7962-7967.
6. Quack I, Rump LC, Gerke P et al. beta-Arrestin2 mediates nephrin endocytosis and impairs slit diaphragm integrity. Proc Natl Acad Sci USA 2006; 103: 14110-14115.
7. Tossidou I, Teng B, Drobot L et al. CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes. J Biol Chem 2010; 285: 25285-25295.
8. Tossidou I, Teng B, Menne J et al. Podocytic PKC-alpha is regulated in murine and human diabetes and mediates nephrin endocytosis. PLoS ONE 2010; 5: e10185.
9. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: A decade on. Nat Rev Mol Cell Biol 2007; 8: 947-956.
10. Klenk C, Humrich J, Quitterer U et al. SUMO-1 controls the protein stability and the biological function of phosducin. J Biol Chem 2006; 281: 8357-8364.
11. Muller S, Ledl A, Schmidt D. SUMO: A regulator of gene expression and genome integrity. Oncogene 2004; 23: 1998-2008.
12. Johnson ES. Protein modification by SUMO. Annu Rev Biochem 2004; 73: 355-382.
13. Kerscher O, Felberbaum R, Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 2006; 22: 159-180.
14. Pichler A, Knipscheer P, Saitoh H et al. The RanBP2 SUMO E3 ligase is neither. Nat Struct Mol Biol 2004; 11: 984-991.
15. Sampson DA, Wang M, Matunis MJ. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem 2001; 276: 21664-21669.
16. Kang JS, Saunier EF, Akhurst RJ et al. The type I TGF-beta receptor is covalently modified and regulated by sumoylation. Nat Cell Biol 2008; 10: 654-664.
17. Miyazono K, Kamiya Y, Miyazawa K. SUMO amplifies TGF-beta signalling. Nat Cell Biol 2008; 10: 635-637.
18. Plant LD, Dementieva IS, Kollewe A et al. One SUMO is sufficient to silence the dimeric potassium channel K2P1. Proc Natl Acad Sci USA 2010; 107: 10743-10748.
19. Tang Z, El FO, Betz H et al. Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. J Biol Chem 2005; 280: 38153-38159.
20. Khoshnoodi J, Hill S, Tryggvason K et al. Identification of N-linked glycosylation sites in human nephrin using mass spectrometry. J Mass Spectrom 2007; 42: 370-379.
21. Yan K, Khoshnoodi J, Ruotsalainen V et al. N-linked glycosylation is critical for the plasma membrane localization of nephrin. J Am Soc Nephrol 2002; 13: 1385-1389.
22. Zhou W, Hannoun Z, Jaffray E et al. SUMOylation of HNF4alpha regulates protein stability and hepatocyte function. J Cell Sci 2012; 125: 3630-3635.
23. Fei E, Jia N, Yan M et al. SUMO-1 modification increases human SOD1 stability and aggregation. Biochem Biophys Res Commun 2006; 347: 406-412.
24. Yang F, Yao Y, Jiang Y et al. Sumoylation is important for stability, subcellular localization, and transcriptional activity of SALL4, an essential stem cell transcription factor. J Biol Chem 2012; 287: 38600-38608.
25. Fukuda I, Ito A, Hirai G et al. Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol 2009; 16: 133-140.
26. Liu L, Done SC, Khoshnoodi J et al. Defective nephrin trafficking caused by missense mutations in the NPHS1 gene: insight into the mechanisms of congenital nephrotic syndrome. Hum Mol Genet 2001; 10: 2637-2644.
27. Xue Y, Zhou F, Fu C et al. SUMOsp: A web server for sumoylation site prediction. Nucleic Acids Res 2006; 34: W254-W257.
28. Huber TB, Hartleben B, Kim J et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 2003; 23: 4917-4928.
29. Doublier S, Salvidio G, Lupia E et al. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003; 52: 1023-1030.
30. Kruse M, Schulze-Bahr E, Corfield V et al. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest 2009; 119: 2737-2744.
31. Martin S, Nishimune A, Mellor JR et al. SUMOylation regulates kainatereceptor-mediated synaptic transmission. Nature 2007; 447: 321-325.
32. Tossidou I, Kardinal C, Peters I et al. CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes. J Biol Chem 2007; 282: 7457-7464.